Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02282319Phase 4Completed
Phase 4, randomised, double-blind trial of dexmedetomidine in knee arthroscopy (3 arms). Primary endpoints: Sensory block regression L2 dermatome up to 360 minutes and Motor block regression up to 240 minutes. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02282319.